The event of cell tradition programs for the naturalistic propagation, self-renewal and differentiation of cells ex vivo is a excessive purpose of molecular engineering. Regardless of vital success in recent times, the excessive value of up-scaling cultures, the necessity for xeno-free tradition situations, and the diploma of mimicry of the natural extracellular matrix attainable in vitro utilizing designer substrates proceed to pose obstacles to the interpretation of cell-based technologies.
On this regard, the ZT biopolymer is a protein-based, steady, scalable, and economical cell substrate of excessive promise. ZT relies on the naturally occurring meeting of two human proteins: titin-Z1Z2 and telethonin. These protein constructing blocks are strong scaffolds that may be conveniently functionalized with full-length proteins and bioactive peptidic motifs by genetic manipulation, previous to self-assembly.
The polymer is, thereby, totally encodable. Functionalized variations of the ZT polymer have been proven to efficiently maintain the long-term culturing of human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), and murine mesenchymal stromal cells (mMSCs).
Pluripotency of hESCs and hiPSCs was retained for the longest interval assayed (four months). Outcomes level to the big potential of the ZT system for the creation of a modular, pluri-functional biomaterial for cell-based purposes.
Maxwell®: An Unsupervised Studying Method for 5P Medication.
Within the 5P medication (Customized, Preventive, Participative, Predictive and Pluri-expert), the final pattern is to course of information by displacing the barycenter of the data from hospital centered programs to the affected person centered ones by his private medical information.
EGF |
|||
| 90201-2 | BPS Bioscience | 500 µg_x000D_ | EUR 220 |
|
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system. |
|||
EGF |
|||
| 90201-3 | BPS Bioscience | 1000 µg | EUR 335 |
|
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system. |
|||
EGF |
|||
| CSB-CL007473HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
EGF |
|||
| GWB-21C95B | GenWay Biotech | 0.5 mg | Ask for price |
EGF |
|||
| GWB-AB1AFA | GenWay Biotech | 1 mg | Ask for price |
EGF |
|||
| GWB-CB9E42 | GenWay Biotech | 0.5 mg | Ask for price |
EGF |
|||
| E21-029 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed. |
|||
EGF |
|||
| E13-007-1 | EnoGene | 10μg | EUR 25 |
|
Description: N/A |
|||
EGF |
|||
| E13-007-2 | EnoGene | 50μg | EUR 50 |
|
Description: N/A |
|||
EGF |
|||
| E8ET1704-33 | EnoGene | 100ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
EGF |
|||
| cyt-217 | ProSpec Tany | 100µg | EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor |
|||
EGF |
|||
| LF-PR003 | Abfrontier | 200 ug | EUR 170.4 |
|
Description: EGF protein |
|||
EGF |
|||
| MBS516949-05mg | MyBiosource | 0.5mg | EUR 325 |
EGF |
|||
| MBS516949-5x05mg | MyBiosource | 5x0.5mg | EUR 1205 |
EGF |
|||
| MO15063 | Neuromics | 100 ug | EUR 490.8 |
EGF |
|||
| MBS8532843-001mg | MyBiosource | 0.01mg | EUR 305 |
EGF |
|||
| MBS8532843-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
EGF |
|||
| MBS8534534-01mL | MyBiosource | 0.1mL | EUR 345 |
EGF |
|||
| MBS8534534-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EGF |
|||
| MBS8534534-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EGF |
|||
| MBS8534534-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EGF |
|||
| MBS8534534-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EGF |
|||
| MBS8560221-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
EGF |
|||
| MBS8560221-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
EGF |
|||
| MBS8560221-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
EGF |
|||
| MBS8560221-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
EGF |
|||
| MBS8560221-02mL | MyBiosource | 0.2mL | EUR 345 |
EGF |
|||
| PR27006 | Neuromics | 500 ug | EUR 97.2 |
EGF |
|||
| PR27006-B | Neuromics | each | EUR 184.5 |
EGF |
|||
| PR27009 | Neuromics | 500 ug | EUR 97.2 |
EGF |
|||
| PR27009-B | Neuromics | each | EUR 184.5 |
HB-EGF (Heparin Binding EGF) |
|||
| MBS517060-005mg | MyBiosource | 0.05mg | EUR 240 |
HB-EGF (Heparin Binding EGF) |
|||
| MBS517060-02mg | MyBiosource | 0.2mg | EUR 405 |
HB-EGF (Heparin Binding EGF) |
|||
| MBS517060-1mg | MyBiosource | 1mg | EUR 1480 |
HB-EGF (Heparin Binding EGF) |
|||
| MBS517060-5x1mg | MyBiosource | 5x1mg | EUR 6405 |
h. EGF |
|||
| EK0325 | Antagene | 1×96T | EUR 550 |
|
Description: ELISA |
|||
m. EGF |
|||
| EK0326 | Antagene | 1×96T | EUR 575 |
|
Description: ELISA |
|||
rHu EGF |
|||
| AK8327-0100 | Akron Biotech | 100µg | Ask for price |
rHu EGF |
|||
| AK8327-0500 | Akron Biotech | 500µg | Ask for price |
rHu EGF |
|||
| AK8327-1000 | Akron Biotech | 1mg | Ask for price |
EGF, Rat |
|||
| HY-P7092 | MedChemExpress | 50ug | EUR 253.2 |
Rat EGF |
|||
| MBS691892-002mg | MyBiosource | 0.02mg | EUR 300 |
Rat EGF |
|||
| MBS691892-01mg | MyBiosource | 0.1mg | EUR 450 |
Rat EGF |
|||
| MBS691892-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
EGF Long |
|||
| cyt-798 | ProSpec Tany | 20µg | EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor Long |
|||
EGF-816; Nazartinib |
|||
| MBS130723-100mg | MyBiosource | 100mg | EUR 1065 |
EGF-816; Nazartinib |
|||
| MBS130723-500mg | MyBiosource | 500mg | EUR 2775 |
Mouse EGF |
|||
| 90200-1 | BPS Bioscience | 100 µg | EUR 85 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
|||
Mouse EGF |
|||
| 90200-2 | BPS Bioscience | 500 µg_x000D_ | EUR 210 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
|||
Mouse EGF |
|||
| 90200-3 | BPS Bioscience | 1000 µg | EUR 320 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
|||
EGF, Mouse |
|||
| HY-P7067 | MedChemExpress | 100ug | EUR 224.4 |
EGF, Human |
|||
| HY-P7109 | MedChemExpress | 50ug | EUR 129.6 |
EGF，Swine |
|||
| E34M018S | EnoGene | 5 μg | EUR 295 |
EGF，Mouse |
|||
| E34M065M | EnoGene | 100 μg | EUR 155 |
EGF， Human |
|||
| E34M120-100HP | EnoGene | 100 μg | EUR 155 |
EGF (Human) |
|||
| MBS408047-01mg | MyBiosource | 0.1mg | EUR 225 |
EGF (Human) |
|||
| MBS408047-5x01mg | MyBiosource | 5x0.1mg | EUR 955 |
Human EGF |
|||
| MBS692154-05mg | MyBiosource | 0.5mg | EUR 305 |
Human EGF |
|||
| MBS692154-5x05mg | MyBiosource | 5x0.5mg | EUR 1080 |
Human EGF |
|||
| MBS691855-01mg | MyBiosource | 0.1mg | EUR 225 |
Human EGF |
|||
| MBS691855-5x01mg | MyBiosource | 5x0.1mg | EUR 725 |
Mouse EGF |
|||
| MBS691939-05mg | MyBiosource | 0.5mg | EUR 450 |
Mouse EGF |
|||
| MBS691939-5x05mg | MyBiosource | 5x0.5mg | EUR 1725 |
Mouse EGF |
|||
| MBS691993-01mg | MyBiosource | 0.1mg | EUR 300 |
Mouse EGF |
|||
| MBS691993-5x01mg | MyBiosource | 5x0.1mg | EUR 1050 |
EGF, Human |
|||
| MBS8575277-01mg | MyBiosource | 0.1mg | EUR 245 |
EGF, Human |
|||
| MBS8575277-5x01mg | MyBiosource | 5x0.1mg | EUR 940 |
EGF, Mouse |
|||
| MBS8575390-01mg | MyBiosource | 0.1mg | EUR 245 |
EGF, Mouse |
|||
| MBS8575390-5x01mg | MyBiosource | 5x0.1mg | EUR 940 |
EGF, Swine |
|||
| MBS8575438-0005mg | MyBiosource | 0.005mg | EUR 370 |
EGF, Swine |
|||
| MBS8575438-5x0005mg | MyBiosource | 5x0.005mg | EUR 1520 |
EGF, Pichia |
|||
| cyt-332 | ProSpec Tany | 100µg | EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor, Pichia |
|||
EGF Pichia |
|||
| PR27007 | Neuromics | 500 ug | EUR 97.2 |
EGF Pichia |
|||
| PR27007-B | Neuromics | each | EUR 184.5 |
EGF protein |
|||
| 30R-2331 | Fitzgerald | 500 ug | EUR 1285 |
|
Description: Purified recombinant Human EGF protein |
|||
EGF protein |
|||
| 30R-2332 | Fitzgerald | 500 ug | EUR 165 |
|
Description: Purified recombinant Mouse EGF protein |
|||
EGF protein |
|||
| 30R-2333 | Fitzgerald | 20 ug | EUR 330 |
|
Description: Purified recombinant Rat EGF protein |
|||
EGF protein |
|||
| 30R-1056 | Fitzgerald | 100 ug | EUR 102 |
|
Description: Purified recombinant Human EGF protein |
|||
EGF protein |
|||
| 30R-AE003 | Fitzgerald | 1 mg | EUR 717 |
|
Description: Purified recombinant Human EGF protein |
|||
EGF protein |
|||
| 30R-AE004 | Fitzgerald | 100 ug | EUR 312 |
|
Description: Purified recombinant Human EGF protein |
|||
EGF protein |
|||
| 30R-AE025 | Fitzgerald | 100 ug | EUR 312 |
|
Description: Purified recombinant Human EGF protein |
|||
EGF Protein |
|||
| abx169012-1mg | Abbexa | 1 mg | EUR 543.6 |
EGF Protein |
|||
| abx069820-1g | Abbexa | 1 g | EUR 1362.5 |
EGF Protein |
|||
| abx069820-1mg | Abbexa | 1 mg | EUR 1296 |
EGF protein |
|||
| MBS538026-01mg | MyBiosource | 0.1mg | EUR 2320 |
EGF protein |
|||
| MBS538026-05mg | MyBiosource | 0.5mg | EUR 465 |
EGF protein |
|||
| MBS538026-5x01mg | MyBiosource | 5x0.1mg | EUR 10295 |
EGF protein |
|||
| MBS538327-1mg | MyBiosource | 1mg | EUR 1940 |
EGF protein |
|||
| MBS538327-5x1mg | MyBiosource | 5x1mg | EUR 8570 |
EGF protein |
|||
| MBS536555-01mg | MyBiosource | 0.1mg | EUR 465 |
EGF protein |
|||
| MBS536555-5x01mg | MyBiosource | 5x0.1mg | EUR 1945 |
EGF protein |
|||
| MBS836477-01mg | MyBiosource | 0.1mg | EUR 235 |
EGF protein |
|||
| MBS836477-5x01mg | MyBiosource | 5x0.1mg | EUR 900 |
EGF Antibody |
|||
| MBS7113626-005mg | MyBiosource | 0.05mg | EUR 190 |
EGF Antibody |
|||
| MBS7113626-01mg | MyBiosource | 0.1mg | EUR 270 |
EGF Antibody |
|||
| MBS7113626-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
EGF Antibody |
|||
| MBS7118149-005mg | MyBiosource | 0.05mg | EUR 150 |
EGF Antibody |
|||
| MBS7118149-01mg | MyBiosource | 0.1mg | EUR 190 |
EGF Antibody |
|||
| MBS7118149-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
EGF Antibody |
|||
| MBS7123634-005mL | MyBiosource | 0.05mL | EUR 190 |
EGF Antibody |
|||
| MBS7123634-01mL | MyBiosource | 0.1mL | EUR 270 |
EGF Antibody |
|||
| MBS7123634-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
EGF Antibody |
|||
| MBS7123635-005mL | MyBiosource | 0.05mL | EUR 190 |
EGF Antibody |
|||
| MBS7123635-01mL | MyBiosource | 0.1mL | EUR 270 |
EGF Antibody |
|||
| MBS7123635-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
EGF antibody |
|||
| 10-E39A | Fitzgerald | 500 ug | EUR 679.2 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF antibody |
|||
| 10R-2038 | Fitzgerald | 100 ul | EUR 468 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF antibody |
|||
| 10R-2176 | Fitzgerald | 100 ul | EUR 468 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF antibody |
|||
| 10R-2969 | Fitzgerald | 100 ug | EUR 218 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF antibody |
|||
| 10R-2985 | Fitzgerald | 100 ug | EUR 218 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF antibody |
|||
| 10R-7766 | Fitzgerald | 500 ug | EUR 678 |
|
Description: Mouse monoclonal EGF antibody |
|||
EGF Antibody |
|||
| 35720 | SAB | 100ul | EUR 319 |
EGF Antibody |
|||
| 35720-100ul | SAB | 100ul | EUR 302.4 |
EGF antibody |
|||
| 20C-CR1085GP | Fitzgerald | 100 ug | EUR 109 |
|
Description: Goat polyclonal EGF antibody |
|||
EGF antibody |
|||
| 20R-1772 | Fitzgerald | 100 ug | EUR 807.6 |
|
Description: Rabbit polyclonal EGF antibody |
|||
EGF antibody |
|||
| 38447 | SAB | 100ul | EUR 439 |
EGF antibody |
|||
| 38447-100ul | SAB | 100ul | EUR 302.4 |
EGF antibody |
|||
| 70R-EG001 | Fitzgerald | 50 ug | EUR 312 |
|
Description: Affinity purified Goat polyclonal EGF antibody |
|||
EGF antibody |
|||
| 70R-ER012 | Fitzgerald | 50 ug | EUR 312 |
|
Description: Affinity purified Rabbit polyclonal EGF antibody |
|||
EGF antibody |
|||
| 70R-5697 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Rabbit polyclonal EGF antibody |
|||
EGF Antibody |
|||
| 49545 | SAB | 100ul | EUR 499 |
EGF Antibody |
|||
| 49545-100ul | SAB | 100ul | EUR 399.6 |
EGF Antibody |
|||
| 49545-50ul | SAB | 50ul | EUR 286.8 |
egf Antibody |
|||
| CAC11577-100ug | Biomatik Corporation | 100ug | EUR 314 |
egf Antibody |
|||
| CAC11577-50ug | Biomatik Corporation | 50ug | EUR 199.2 |
EGF Antibody |
|||
| 5022-100 | Biovision | each | EUR 379.2 |
EGF Antibody |
|||
| 5022-30T | Biovision | each | EUR 175.2 |
EGF Antibody |
|||
| 5023R-100 | Biovision | each | EUR 379.2 |
EGF Antibody |
|||
| 5023R-30T | Biovision | each | EUR 175.2 |
In the present day, using synthetic intelligence for supporting this transition exhibits actual limitations in its implementation in operational follow, each on the stage of affected person care, but in addition within the basic each day lifetime of the well being skilled, due to the medico-legal imperatives induced by the guarantees of the ‘5P medication’.
On this paper, we suggest to fill this hole by introducing an authentic synthetic intelligence platform, named Maxwell, which follows an unsupervised studying method consistent with the medico-legal imperatives of the ‘5P medication’. We describe the useful platform traits and illustrate them by two examples of clustering in genomics and magnetic resonance imaging.